REGULATORY

Amendment of PMD Law Will Be Top Priority in 2019: MHLW Bureau Chief Miyamoto

January 8, 2019

- Only subscribers can save articles.
  
  Sign In
  
  Subscribe

As the Ministry of Health, Labor and Welfare (MHLW) plans to send a bill related to the amendment of the Pharmaceuticals and Medical Devices (PMD) Law to the next ordinary Diet session, which will convene later this month, its pharma…

To read the full story

MHLW Compiles Proposal for PMD Law Amendment, Eyes Diet Submission of Related Bill Next Year
December 18, 2018

REGULATORY

Japan Panel Green-Lights Pfizer’s Tukysa, Wider Labels for Tezspire, and More Drugs
January 30, 2026
MHLW to Ease Uniform Driving Restrictions on Oral Antiepileptics
January 29, 2026
MHLW Eyes Distribution Rules in Revamped Supply Support Premium: Chuikyo
January 29, 2026
Entyvio, Rexulti, and Lenvima among 15 More Drugs Picked for IRA Price Talks
January 29, 2026
Japan’s Lower House Campaign Begins amid Fragmented Political Set-Up
January 28, 2026

Chuikyo Debate on FY2026 Drug Pricing Reform

Chuikyo OKs New CEA Handling, with Third-Party Verification Ahead

Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…

COMMENTARY

TSE’s Growth Market Reform Puts Pressure on Biotechs

By Tatsuya Otsuka

Japan’s biotech startups are coming under growing pressure as the Tokyo Stock Exchange (TSE) tightens its rules for companies listed…

COLUMN

AI in Healthcare Hiring: Leveling the Playing Field & Unlocking Human Potential

By Philip Carrigan

The Japanese healthcare sector is experiencing rapid growth, demanding a highly skilled and diverse workforce. However, finding and attracting the best talent in this competitive market presents significant challenges.Enter AI. With the rise of AI-powered tools, healthcare organizations can revolutionize…